New funding opportunity for early-career faculty now accepting applications
The COVID-19 pandemic has exposed the special challenges facing early-career faculty who are balancing family caregiving responsibilities with building their biomedical research careers.
Now, new funding from national nonprofits and internal resources will help support selected U-M Medical School faculty facing this situation. On Wednesday, Nov. 17, the Doris Duke Charitable Foundation, in concert with the American Heart Association, the Burroughs Wellcome Fund and the John Templeton Foundation announced that Michigan Medicine was selected as one of 22 academic medical institutions to receive funds from a new $12.1 million COVID-19 Fund to Retain Clinical Scientists.
Michigan Medicine is requesting applications for the COVID-19 Fund to Retain Clinical Scientists (FRCS). The FRCS program provides support for research supplements to clinical and translational scientists at the time of a caregiving crisis to: 1) advance clinical and translational research in an inclusive way, 2) enable recipients to repurpose their time so their research can continue, and 3) validate rather than reinforce stigma around caregiving in clinical and translational research.
Nine applicants will be selected to receive $100,000 (funds must be used by Sept. 30, 2023).
The deadline to apply is Feb. 28, 2022. More detailed information and eligibility requirements can be found in Competition Space.
Q&A Town Hall
Friday, Dec. 10
Noon – 1 p.m.
Zoom (Passcode: 924067)